Private Equity
Quad-C Management Inc has sold its investment in VMG Health to Northlane Capital Partners.
3 min read · 25 March 2020
While many traditional PE shops are busy assessing the potential impacts of covid-19 on their portfolios, a few are turning to their companies to develop vaccines and tests to curb the spread of coronavirus.
4 min read · 24 March 2020
Toronto-based Centric Health Corp has agreed to acquire Remedy Holdings and Remedy'sRx specialty pharmacy business for up to C$44 million.
7 min read · 24 March 2020
The Riverside Company has made an investment in Red Nucleus Enterprises LLC, a provider of learning and compliance services to customers in the pharmaceutical industry.
2 min read · 24 March 2020
Eye Health America, which was formed by LLR Partners, has acquired two South Carolina-based optometry practices, Dillon Eyecare Associates and Pee Dee Eye Associates.
3 min read · 23 March 2020
The test is said to indicate whether a person has ever had covid-19 or is a carrier without symptoms. Testing today only indicates whether someone displaying symptoms actually has the disease.
4 min read · 23 March 2020
Imprivata, which helps healthcare providers protect patient information, was anticipated to command upwards of $2bn in a potential sale.
2 min read · 20 March 2020
Arcadia Consumer Healthcare Inc, which is backed by Avista Capital Partners, has acquired anti-diarrheal medicine Kaopectate from Sanofi.
2 min read · 20 March 2020
Areas of the healthcare industry will likely be triggered into action, spurring innovation, as bottlenecks in the system become increasingly clear amid covid-19, Adams told PE Hub.
3 min read · 19 March 2020
Telehealth tackles the coronavirus and CapVest-backed Curium calls off its potential $3 billion sale.
4 min read · 19 March 2020
